Key Takeaways
- PayPal (PYPL) shares declined after projecting stagnant adjusted earnings for 2026, though turnaround initiatives offer hope
- CVS Health (CVS) delivered $402.1 billion in 2025 revenue and expects similar performance in 2026 with improved margins
- Nike (NKE) reported Q3 2026 revenues of $11.3 billion with wholesale channels gaining 5% and North American sales trending positive
- HP (HPQ) delivered Q1 2026 revenues of $14.4 billion, marking 6.9% annual growth, while projecting $2.8–$3.0 billion in free cash flow
- Estée Lauder (EL) disappointed investors with conservative 2026 projections despite exceeding earnings expectations
Investors seeking value opportunities in 2026 are keeping close tabs on PayPal, CVS Health, Nike, HP, and Estée Lauder—five companies trading at depressed valuations.
These aren’t merely discounted equities. They represent a specific investment thesis: market pessimism combined with tangible catalysts that could trigger valuation re-ratings.
Companies Attempting Comebacks
PayPal
PayPal exemplifies how subdued expectations can create opportunity when recovery materializes. According to Reuters reporting in February, the payments giant projected essentially flat or marginally declining adjusted earnings for 2026, missing analyst projections.
Shares tumbled following executive transitions that sparked concerns about strategic direction. However, successful improvements to branded checkout conversion rates and enhanced Venmo revenue generation could reposition the stock as a recovering digital payments leader.
CVS Health
CVS Health continues trading at attractive multiples given its operational scale. The healthcare giant posted 2025 full-year revenues reaching $402.1 billion. For 2026, executives projected adjusted earnings per share between $7.00 and $7.20, with revenues expected to reach at least $400 billion.
A complete business transformation isn’t necessary for upside. Modest profitability improvements across its insurance and pharmacy segments could prompt investors to reassess the company as a stable cash-generating enterprise.
Nike
Nike remains viewed skeptically as an overly complex turnaround situation. The athletic apparel leader’s fiscal Q3 2026 results, announced March 31, showed revenues of $11.3 billion with wholesale channels advancing 5%. The North American market also posted gains.
Gross profitability weakened, and certain divisions continue struggling. Yet selective improvement across key metrics suggests the foundation for a valuation rebound may be forming.
Cash Generation and Operational Recovery
HP
HP delivered fiscal Q1 2026 revenues of $14.4 billion, representing 6.9% year-over-year expansion. Non-GAAP diluted earnings per share increased 9.5%, while free cash flow reached $175 million. Management reaffirmed full-year free cash flow projections of $2.8 billion to $3.0 billion.
The investment case hinges on sustained PC market stabilization and accelerating adoption of AI-enabled computers. HP doesn’t require explosive top-line expansion—consistent earnings stability should suffice for share price appreciation.
Estée Lauder
Estée Lauder represents the most speculative opportunity among these five companies. Reuters reported in February that shares retreated following disappointing fiscal 2026 guidance, despite the company surpassing profit estimates.
Executives outlined turnaround plans emphasizing new product introductions, marketing investments, and premium brand positioning. The market remains concerned about sluggish U.S. consumer demand, tariff impacts, and execution uncertainty.
Based on current guidance, Estée Lauder has yet to demonstrate sustainable revenue expansion or margin enhancement.
Final Thoughts
These five equities share a unifying characteristic. Market sentiment remains cautious, yet each possesses legitimate catalysts capable of transforming investor perception throughout 2026.


